Immunology and Cell Biology - Table of Contents alert Volume 95 Issue 4

If you are unable to see the message below, click here to view.

Advertisement Nature Milestones: Interactive antibody timeline Nature Milestones: Antibodies presents an interactive timeline on the history of antibodies covering everything from their initial description in antisera through to their application in immunotherapy. The timeline includes written content, video interviews and animations.  Access the timeline free online Produced with support from BioLegend UCB  The April 2017 issue of Immunology & Cell Biology contains a Special Feature on Cancer Immunotherapy. This series of reviews highlights some of the recent advances in mobilizing effective host immunity to cancer. Cancer immunotherapy is at a critical and exciting stage of development. Progress in our understanding of cancer immunotherapy has been dramatic over recent years and we have selected six articles to highlight in this Special Feature. The Special Feature begins with an overview of the approaches to targeting inflammation in the cancer microenvironment and follows with a focus of extracellular adenosine as a major immunosuppressive metabolite in tumours. Two subsequent articles detail advances in antibody engineering for engaging the ideal effector responses in tumours and the Special Feature finishes with two articles that explore new approaches in adoptive cellular therapy targeted at tumor and virus specific antigens in tumors. Immunology & C ell Biology thanks the coordinator of this Special Feature – Mark Smyth – for his planning and input. Please see articles marked TABLE OF CONTENTS Volume 95, Issue 4 (April 2017) In this issue News and Commentary Editorial Reviews Original Articles Short Communication Retraction Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe News and Commentary Top When input does not match output, lung-resident memory T cells decay Linda M Wakim Immunol Cell Biol 2017 95: 321-322; advance online publication, March 14, 2017; 10.1038/icb.2017.14 Full Text Editorial Top Multiple approaches to immunotherapy - the new pillar of cancer treatment   Mark J Smyth Immunol Cell Biol 2017 95: 323-324; 10.1038/icb.2017.9 Full Text | PDF Reviews Top Targeting cancer-related inflammation in the era of immunotherapy   Kyohei Nakamura and Mark J Smyth Immunol Cell Biol 2017 95: 325-332; advance online publication, January 10, 2017; 10.1038/icb.2016.126 Abstract | Full Text Targeting A2 adenosine receptors in cancer   David Allard, Martin Turcotte and John Stagg Immunol Cell Biol 2017 95: 333-339; advance online publication, February 8, 2017; 10.1038/icb.2017.8 Abstract | Full Text Role of Fc–FcγR interactions in the antitumor activity of therapeutic antibodies   Bryan C Barnhart and Michael Quigley Immunol Cell Biol 2017 95: 340-346; advance online publication, December 15, 2016; 10.1038/icb.2016.121 Abstract | Full Text Antibody-dependent cell cytotoxicity: immunotherapy strategies enhancing effector NK cells   Maria Carmen Ochoa, Luna Minute, Inmaculada Rodriguez, Saray Garasa, Elisabeth Perez-Ruiz, Susana Inogés, Ignacio Melero and Pedro Berraondo Immunol Cell Biol 2017 95: 347-355; advance online publication, February 21, 2017; 10.1038/icb.2017.6 Abstract | Full Text CAR T-cell therapy of solid tumors   Carmen S M Yong, Valerie Dardalhon, Christel Devaud, Naomi Taylor, Phillip K Darcy and Michael H Kershaw Immunol Cell Biol 2017 95: 356-363; advance online publication, December 22, 2016; 10.1038/icb.2016.128 Abstract | Full Text Adoptive cellular immunotherapy for virus-associated cancers: a new paradigm in personalized medicine   Corey Smith and Rajiv Khanna Immunol Cell Biol 2017 95: 364-371; advance online publication, January 10, 2017; 10.1038/icb.2016.127 Abstract | Full Text Original Articles Top Monocytic thrombomodulin promotes cell adhesion through interacting with its ligand, Lewisy OPEN Wei-Ling Lin, Chia-Chi Chen, Guey-Yueh Shi, Chih-Yuan Ma, Chuan-Fa Chang and Hua-Lin Wu Immunol Cell Biol 2017 95: 372-379; advance online publication, November 3, 2016; 10.1038/icb.2016.110 Abstract | Full Text Hypoxic modulation of hepatocyte responses to the cytokine interleukin-22 Scott A Budda, Krishna Bhattarai, Justine L Alexander and Lauren A Zenewicz Immunol Cell Biol 2017 95: 380-387; advance online publication, October 31, 2016; 10.1038/icb.2016.107 Abstract | Full Text Inhibition of MHC-I by Brucella abortus is an early event during infection and involves EGFR pathway Lis N Velásquez, M Ayelén Milillo, M Victoria Delpino, Aldana Trotta, M Florencia Mercogliano, Roberto G Pozner, Roxana Schillaci, Patricia V Elizalde, Guillermo H Giambartolomei and Paula Barrionuevo Immunol Cell Biol 2017 95: 388-398; advance online publication, November 29, 2016; 10.1038/icb.2016.111 Abstract | Full Text Vascular endothelial growth factor promotes the activation of hepatic stellate cells in chronic schistosomiasis Jie Luo, Yuejin Liang, Fanping Kong, Jingfan Qiu, Xinjian Liu, Ailing Chen, Bruce A Luxon, Hannah W Wu and Yong Wang Immunol Cell Biol 2017 95: 399-407; advance online publication, November 3, 2016; 10.1038/icb.2016.109 Abstract | Full Text Short Communication Top Metabolic sialic acid blockade lowers the activation threshold of moDCs for TLR stimulation Christian Büll, Estel Collado-Camps, Esther D Kers-Rebel, Torben Heise, Jonas N Søndergaard, Martijn H den Brok, Barbara M Schulte, Thomas J Boltje and Gosse J Adema Immunol Cell Biol 2017 95: 408-415; advance online publication, November 22, 2016; 10.1038/icb.2016.105 Abstract | Full Text Retraction Top Decidual vascular endothelial cells promote maternal–fetal immune tolerance by inducing regulatory T cells through canonical Notch1 signaling Yanyi Yao, Jieping Song, Weipeng Wang and Nian Liu Immunol Cell Biol 2017 95: 416; 10.1038/icb.2017.12 Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Immunology & Cell Biology. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Springer Nature's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2017 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.